DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $16.5 million in its first quarter.
On a per-share basis, the Dublin-based company said it had a loss of 4 cents. Earnings, adjusted for non-recurring costs and stock option expense, came to 2 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.
The biopharmaceutical company posted revenue of $86 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $82.6 million.
The company’s shares closed at $1.41. A year ago, they were trading at $2.73.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.